(Q40602815)

21 September 2017

1 reference

title

Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure (English)

1 reference

21 September 2017

A J Coats

1

1 reference

21 September 2017

S Adamopoulos

series ordinal

2

1 reference

21 September 2017

publication date

1 October 1994

1 reference

Cardiovascular Drugs and Therapy

21 September 2017

published in

1 reference

21 September 2017

volume

8

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

685-692

1 reference

Neurohormonal interactions and adaptations in congestive heart failure

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00877115

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00877115

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00877115

Selective enhancement of the cardiac sympathetic response to exercise by anginal chest pain in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00877115

Prognostic Value of Heart Rate Variability in Patients Awaiting Cardiac Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00877115

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

21 January 2018

1 reference

12 December 2020

Neuroendocrine response in acute heart failure and the influence of treatment

1 reference

12 December 2020

Plasma Atrial Natriuretic Peptide Level As an Index for the Severity of Congestive Heart Failure

1 reference

12 December 2020

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

12 December 2020

The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure

1 reference

12 December 2020

Digoxin, Converting-Enzyme Inhibition (Quinapril), and the Combination in Patients with Congestive Heart Failure Functional Class II and Sinus Rhythm

1 reference

12 December 2020

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control

1 reference

12 December 2020

Neurohumoral mechanisms involved in congestive heart failure

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

12 December 2020

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Defective cardiac parasympathetic control in patients with heart disease

1 reference

12 December 2020

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

12 December 2020

Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease

1 reference

12 December 2020

Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration

1 reference

12 December 2020

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

1 reference

12 December 2020

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

12 December 2020

Plasma norepinephrine in congestive heart failure

1 reference

12 December 2020

Myocardial infarction and baroreflex sensitivity. Clinical studies

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

Renin relationships in congestive cardiac failure, treated and untreated

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00877115

1 reference

21 September 2017

1 reference